Short Summary
The petitions challenged orders passed by the Assistant Controller of Patents rejecting patent applications or related documents. The court examined the statutory scheme of the Patents Act, particularly concerning pre-grant and post-grant opposition procedures introduced by the 2005 Amendment Act.
Detailed Summary
In the high-stakes world of pharmaceutical patents, the instinct to rush to the highest court for relief is understandable—but it can also be fatal to your case. The dispute between UCB Farchim SA and Cipla Ltd. is a textbook example of how choosing the wrong legal door can slam your chances of ever being heard. This case underscores a critical lesson for founders and IP professionals: when the law provides a specific appellate pathway, bypassing it in favor of a writ petition can result in immediate dismissal.
UCB Farchim SA, a Swiss pharmaceutical company, found itself at odds with orders passed by the Assistant Controller of Patents that rejected its patent applications or related documents. Rather than following the statutory route designed for challenging such decisions, UCB Farchim chose to approach the High Court directly through writ petitions. The respondent in the matter was Cipla Ltd. and others, an Indian pharmaceutical major with its own interests in the patent landscape. The dispute arose against the backdrop of the 2005 Amendment Act to the Patents Act, which introduced significant changes to the framework governing pre-grant and post-grant opposition procedures—reshaping how patent applications could be contested before and after grant.
UCB Farchim's central argument rested on its right to seek judicial review of the Assistant Controller's orders through a writ petition under Article 226 of the Constitution. The company appeared to contend that the rejections warranted immediate intervention by the High Court. On the other side, the respondents and the court itself examined the statutory scheme of the Patents Act with particular attention to the pre-grant and post-grant opposition mechanisms introduced by the 2005 Amendment Act. The legal friction centered on a fundamental question: when a specialized statutory remedy exists, can a party bypass it and invoke the extraordinary jurisdiction of the High Court? The court scrutinized whether the writ route was even available given the comprehensive framework the Patents Act had put in place.
The court dismissed the petitions, holding that a writ petition under Article 226 was not the appropriate remedy to challenge orders passed by the Assistant Controller of Patents. Instead, the court made clear that any party aggrieved by such orders should file an appeal before the Intellectual Property Appellate Board (IPAB) under Section 117A of the Patents Act. By directing litigants to the statutorily prescribed appellate forum, the court reinforced the principle that statutory remedies must be exhausted before extraordinary constitutional jurisdiction can be invoked. The petitions were disposed of without reaching the merits of the underlying patent disputes.
For founders, startup leaders, and IP professionals, the lesson is unambiguous: know your appellate pathway before you litigate. The Patents Act provides a structured, specialized route for challenging decisions of the patent office—through appeals to the IPAB under Section 117A. Treating the High Court's writ jurisdiction as a shortcut not only wastes time and resources but can result in outright dismissal without your arguments ever being heard on the merits. Always map out the statutory remedies available under the relevant IP law before deciding on a litigation strategy. In IP disputes, the right forum is just as important as the right argument.
Practitioner Note
This case demonstrates the evidentiary and procedural standards applied in patent matters before Delhi High Court. Understanding the court's reasoning in M/S UCB FARCHIM SA vs M/S Cipla Ltd. is valuable context for structuring arguments or assessing risk in similar proceedings.
Related Cases
The North Face Apparel CorpvsController of Patents and Designs
The North Face Apparel Corp challenged the Controller of Patents' refusal of its patent application (No. 202147026139) titled 'Systems and Methods for End-to-End Article Management' before the Madras High Court under Section 117A of the Patents Act, 1970. The Controller had rejected the application citing lack of inventive step over prior art documents D21-D24. The Court held that the Controller erred by dissecting the claims into isolated elements rather than assessing the invention as a whole, and overlooked the use of spectrophotometer and invisible markers for tracking the manufacturing process, which were not disclosed in the cited prior art. The appeal was allowed and the Controller was directed to grant the patent.
Aventose Energy Private LimitedvsThe Assistant Controller of Patents & Designs, Patent Office Chennai
Aventose Energy Private Limited appealed under Section 117A of the Patents Act, 1970 against the refusal of its patent application (No. 202141019671) for a 'System and Method for Operating Automobiles with an Electric Drivetrain' featuring safe mode activation upon fault detection. The Madras High Court found that the Assistant Controller had contradicted the First Examination Report (which accepted novelty) by subsequently holding the invention lacked novelty without giving the applicant an opportunity to be heard. The court further held that the Controller improperly conflated novelty with inventive step under Section 2(1)(ja) and failed to properly analyze the claims against prior art documents D1–D4.
Apex Laboratories Pvt LtdvsElder Lifescience and Ambico Ayurvedic Health Care
Apex Laboratories Pvt Ltd, the prior adopter and registered proprietor of the trademark ZINCOVIT (TM No. 487453 in Class 5) since 1988, sought interim injunction against Elder Lifescience and Ambico Ayurvedic Health Care for using the deceptively similar mark NEO ZINCOVIT. The applicant also claimed copyright infringement of its registered artistic works (A-108878/2014) covering colour scheme, get-up, and layout. The Madras High Court was satisfied that the respondents were attempting to piggyback on the applicant's goodwill and granted interim injunctions on all three applications covering trademark infringement, copyright infringement, and passing off.
Radico Khaitan LimitedvsPicadilly Agro Industries Limited
This Special Leave Petition arose from a judgment dated 29-05-2026 in CS No. 8/2025 passed by the District Judge, Karnal, Haryana, concerning a trademark dispute over the marks 'Cashmere' and 'Kashmyr' used in relation to beer and vodka. The Supreme Court noted that a First Appeal (FAO-COM-11-2026) was already pending before the Division Bench of the Punjab and Haryana High Court, listed for 28.10.2026. The Court disposed of the SLP without adjudicating it on merits, requesting the High Court to pass an appropriate order regarding the ad interim injunction on the scheduled date.
Maharaja Agrasen Technical Educational Society (Regd.)vsMaharaja Agrasen Himalayan Garhwal University
The plaintiff, Maharaja Agrasen Technical Educational Society, filed a suit for permanent injunction against the defendant, Maharaja Agrasen Himalayan Garhwal University, alleging infringement and passing off regarding the use of the words 'Maharaja Agrasen' in the defendant's name. The Delhi High Court had previously granted a restraint order on 10.07.2026. During the pendency of the suit, the parties arrived at a settlement dated 14.09.2026, under which the defendant agreed to change its name through a statutory amendment while being permitted limited transitional use of its existing name. The court recorded the settlement, modified the interim order accordingly, and listed the matter for compliance reporting on 13.07.2027.
Varahi Diamonds And Finance LimitedvsSahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr.
This is a commercial suit filed by Varahi Diamonds And Finance Limited against Sahil Vinay Mehra Trading As Mehra Sons Jewellers & Anr. before the Delhi High Court. The order is primarily procedural, dealing with the registration of the plaint, issuance of summons, directions for filing pleadings, and an interim injunction application. The matter was referred to mediation, with parties directed to appear before the Delhi High Court Mediation and Conciliation Centre.
Dealing with a patent challenge?
Whether it's a Section 3(d) rejection, a post-grant opposition, or a FRAND dispute, Arctic's patent litigation team has handled it. Get a strategy call.
Disclaimer: This page contains an automated summary based on publicly available judicial records. The content is generated for informational purposes only and does not constitute legal advice. Always verify details against the original source judgment before relying on this information for any legal purpose. If you believe any information is inaccurate, please contact us.